GILL JOHN 4
4 · Altimmune, Inc. · Filed Sep 30, 2022
Insider Transaction Report
Form 4
GILL JOHN
Director
Transactions
- Award
Stock Options (option to buy)
2022-09-29+23,500→ 23,500 totalExercise: $12.62Exp: 2032-09-29→ Common Stock, par value $0.0001 (23,500 underlying)
Footnotes (1)
- [F1]The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 29, 2022, subject to the reporting person's continued service through the applicable vesting date.